missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ HRASLS5 Polyclonal Antibody

Description
Immunogen sequence: LVQLPAKQPP PGTLEQGRSI QQGEKAVVSL ETTPSQKADW SSIPKPENEG KLIKQAAEGK PRPRPG Antigen sequence identity: Mouse 50%; Rat 38%.
Exhibits both phospholipase A1/2 and acyltransferase activities (PubMed:22825852, PubMed:26503625). Shows phospholipase A1 (PLA1) and A2 (PLA2) activity, catalyzing the calcium-independent release of fatty acids from the sn-1 or sn-2 position of glycerophospholipids (PubMed:22825852). Shows N-acyltransferase activity, catalyzing the calcium-independent transfer of a fatty acyl group at the sn-1 position of phosphatidylcholine (PC) and other glycerophospholipids to the primary amine of phosphatidylethanolamine (PE), forming N-acylphosphatidylethanolamine (NAPE), which serves as precursor for N-acylethanolamines (NAEs) (PubMed:19000777, PubMed:22825852). [UniProt].
Specifications
Specifications
| Antigen | HRASLS5 |
| Applications | Immunocytochemistry |
| Classification | Polyclonal |
| Concentration | 0.1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 |
| Gene | HRASLS5 |
| Gene Accession No. | Q96KN8 |
| Gene Alias | 1700055A14Rik; 1700086E08Rik; 4921526K24Rik; Ca(2+)-independent N-acyltransferase; Ca-independent N-acyltransferase; calcium-independent phosphatidylethanolamine N-acyltransferase; HRAS like suppressor family member 5; HRAS-like suppressor 5; HRAS-like suppressor family, member 5; Hrasls5; H-rev107-like protein 5; HRLP5; HRSL5; iNAT; lecithin-retinol acyltransferase (LRAT)-like protein-1; Phospholipase A and acyltransferase 5; PLAAT5; RGD1308376; RLP1; testicular tissue protein Li 90 |
| Gene Symbols | HRASLS5 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?